Page 4 - Sohini Das

Electric 2W rush hits supply roadblock as OEMs struggle to meet demand

Rising demand triggers high waiting period for major brands

GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar

GSK India aims to double revenue to ₹8,000 crore by FY30, with oncology and adult vaccines emerging as key growth drivers alongside its general-medicines portfolio

Festival stocking lifts July auto wholesale dispatches; 2W exports jump 28%

Passenger vehicles, two-wheelers and three-wheelers posted double-digit growth in July, while two-wheeler exports rose 27.7 per cent as the auto industry entered the festive season

TaMo PV Q1 PAT falls 80% as JLR volumes, higher commodity costs weigh

TaMo eyes 70% volume growth in EVs for FY27; expects domestic PV industry to grow 10%

After Ratan Tata's demise, an unravelling script engulfs the Tata group

Divisions over governance, Tata Sons' listing, the SP Group's exit and mounting business losses eroded the consensus behind Chandrasekaran's proposed third term

Who's next for Tata Sons as Chandra steps away? A winding road ahead

Tata Sons must constitute a selection committee to choose its next chairman amid governance disputes at Tata Trusts and unresolved questions over listing and the SP Group

Chandrasekaran's exit brings 158-yr-old empire at a governance crossroads

While many business groups in India follow a trust structure, experts said it works as long as the promoter, the board and professional management are on the same page

The currency effect: Fx-driven hikes steer buyers towards used luxury cars

BMW's used-car sales jump 54% in H1; Audi sold nearly one pre-owned car for every new vehicle in 2025; Mercedes-Benz reports double-digit growth

Indegene eyes clinical research acquisition to widen pharma services play

The company is evaluating specialised CROs, data-management and patient-recruitment businesses as it looks to expand across the pharmaceutical value chain

Tractor retail sales defy El Niño worries, rise 25% in April-July

Registrations hit record July high as rainfall recovery, kharif sowing and healthy farm cash flows support rural demand

FMCG to automobiles: India Inc counting the cost of West Asia conflict

While several firms have responded with calibrated price increases to protect margins, many signalled that further price escalations could follow

US may gain edge in India trade talks over Russian oil purchases: Experts

US senate passes bill threatening 100% tariff on top russian oil buyers

Govt weighs incorporating trade-margin rationalisation into DPCO

No deadline set for policy; non-scheduled drugs account for 82% of market, average channel markup on common dosage forms is 43%

CGHS dues delayed by up to 18 months, strain private hospital finances

Providers say delayed payments, unexplained claim rejections and below-cost reimbursement for some cancer drugs are straining finances despite recently revised CGHS rates

'India began drug discovery before China, but China has moved years ahead'

India's pharma industry must pivot from global leadership in generics to innovation, backed by stronger policy, R&D funding and regulatory reforms, says Satish Reddy

Molbio eyes overseas growth after OptraScan secures USFDA clearance

Molbio Diagnostics plans to expand its overseas business through subsidiary OptraScan after the latter secured USFDA clearance, while diversifying beyond tuberculosis-focused public-health revenues.

Audi India targets doubling India luxury-car share in three years

Audi expects sales to remain broadly flat in 2026 before returning to growth in 2027 as the new models begin contributing

Anand Mahindra calls Class of 2026 a 'superhero generation' amid AI era

Anand Mahindra says old career templates no longer hold as jobs appear and disappear rapidly

Indian drugmakers in no rush to shift to US despite tariff threat

Indian pharma companies are expanding selectively in the US for complex products while retaining India as their manufacturing base despite Trump's tariff threat

Ramkrishna Forgings expects exports to recover on stronger global orders

The company expects exports to contribute 35 per cent of FY27 revenue as demand improves in North America and Europe, helping absorb newly created manufacturing capacity